HONG KONG, Oct 13, 2025 - (ACN Newswire) – Kangji Medical Holdings Limited (“Kangji Medical” or the “Company”, Stock Code: 9997.HK) and Knight Bidco Limited (the “Offeror”) today announced that a circular in relation to the proposed privatisation of Kangji Medical (the “Scheme Document”) has been published, setting out the terms and conditions of the proposed privatisation of Kangji Medical (the “Proposal”) by way of a scheme of arrangement.

The document is now available on the Stock Exchange of Hong Kong’s website. (website link) 

The Proposal represents an attractive opportunity for Scheme Shareholders to realise their investment in the Company with certainty amidst market volatility, potential geopolitical risk, industry and macro uncertainty.

Recommendation

The Independent Board Committee (“IBC”), having considered the Proposal, the Scheme, and the Special Deal, and having taken into account the advice of the Independent Financial Adviser, considers that the Proposal, the Scheme, and the Special Deal are fair and reasonable insofar as the Independent Shareholders are concerned.

Accordingly, the IBC recommends that the Independent Shareholders vote in favour of various resolutions to render the Scheme effective.

Further information on the reasons for the IBC’s recommendation, and the Independent Financial Adviser’s report are available in the Scheme Document.

Action required by Scheme Shareholders

All shareholders are advised to review the Scheme Document. Shareholders should refer to the Scheme Document for further information regarding the Proposal, the Scheme and the Special Deal, as well as the Notices of the Court Meeting and the EGM, together with the forms of proxy in relation thereto.

In accordance with the directions of the Grand Court, the Court Meeting will be held at 10:00 a.m. (Hong Kong time) on 10 November 2025 at United Conference Centre, 10/F, United Centre, 95 Queensway, Admiralty, Hong Kong. The EGM will be held at the same place and on the same date at 10:30 a.m.

Kangji Medical shareholders should carefully read the Scheme Document in its entirety before making a decision with respect to the Scheme.

Background to the Proposal

On 17 July 2025, the Offeror requested the Board to put forward the Proposal to the Shareholders for the privatisation of the Company by way of a scheme of arrangement under section 86 of the Companies Act. Upon completion of the Proposal, the Company will become a wholly-owned subsidiary of the Offeror and the listing of the Shares will be withdrawn from the Stock Exchange.